Published in Calcif Tissue Int on August 01, 2003
Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int (2011) 1.33
Does alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women. BMC Musculoskelet Disord (2005) 1.27
Development and internal validation of the male osteoporosis risk estimation score. Ann Fam Med (2007) 0.96
Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis. Clin Rheumatol (2006) 0.93
Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study. Osteoporos Int (2014) 0.88
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2006) 0.88
Osteoporosis in the aging male: treatment options. Clin Interv Aging (2007) 0.87
Causes, consequences, and treatment of osteoporosis in men. Drug Des Devel Ther (2013) 0.87
Ileum resection is the most predictive factor for osteoporosis in patients with Crohn's disease. Osteoporos Int (2006) 0.85
Comparison of the effects of alendronate and alfacalcidol on hip bone mineral density and bone turnover in Japanese men having osteoporosis or osteopenia with clinical risk factors for fractures. Yonsei Med J (2009) 0.81
The evidence for efficacy of osteoporosis treatment in men with primary osteoporosis: a systematic review and meta-analysis of antiresorptive and anabolic treatment in men. J Osteoporos (2011) 0.80
Treatment for older men with fractures. Osteoporos Int (2011) 0.80
The effects of weekly alendronate therapy in Taiwanese males with osteoporosis. J Bone Miner Metab (2009) 0.80
Comparison of Bone Mineral Density in Lumbar Spine and Fracture Rate among Eight Drugs in Treatments of Osteoporosis in Men: A Network Meta-Analysis. PLoS One (2015) 0.80
The aging spine: new technologies and therapeutics for the osteoporotic spine. Eur Spine J (2003) 0.79
Bisphosphonate treatment in ochronotic osteoporotic patients. Clin Rheumatol (2006) 0.79
Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures. Ther Clin Risk Manag (2010) 0.78
The osteoporotic male: overlooked and undermanaged? Clin Interv Aging (2007) 0.76
Characteristics associated with bone mineral density responses to alendronate in men. Calcif Tissue Int (2013) 0.75
Comparison of the Male Osteoporosis Risk Estimation Score (MORES) With FRAX in Identifying Men at Risk for Osteoporosis. Ann Fam Med (2016) 0.75
Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials. Osteoporos Int (2015) 0.75
Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures. Clin Rheumatol (2014) 0.75
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg (1991) 2.55
Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg (1999) 2.00
Cholecystoenteric fistula (CF) is not a contraindication for laparoscopic surgery. Surg Endosc (2001) 1.87
Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res (1995) 1.79
Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. JAMA (2001) 1.72
Health-related quality of life and radiographic vertebral fracture. Osteoporos Int (2003) 1.70
Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int (1999) 1.59
Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2002) 1.56
Morbidity and mortality after hepatic resection of metastases from colorectal cancer. Br J Surg (1995) 1.54
Adequacy of margins of resection in gastrectomy for cancer. Ann Surg (1982) 1.52
Double versus single stapling technique in rectal anastomosis. Int J Colorectal Dis (1992) 1.47
The variable incidence of hip fracture in southern Europe: the MEDOS Study. Osteoporos Int (1994) 1.46
Improving adherence to and persistence with oral therapy of osteoporosis. Osteoporos Int (2015) 1.46
Role of surgery in patients with primary non-Hodgkin's lymphoma of the stomach: an old problem revisited. Br J Surg (1993) 1.46
Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach. Ann Surg (1987) 1.46
Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2003) 1.45
Comparing reconstruction with Roux-en-Y to a pouch following total gastrectomy. J Am Coll Surg (1996) 1.44
Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. Am J Epidemiol (2005) 1.44
Urinary calcium excretion in the monitoring of bone metastases from prostatic carcinoma. Cancer (2001) 1.43
Proceedings: The value of staging laparotomy in non-Hodgkin's lymphomas (with emphasis on the histiocytic type). Cancer (1974) 1.43
Sjögren's syndrome and pure red cell aplasia. Clin Exp Rheumatol (1996) 1.37
Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience. Bone (2003) 1.34
Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastrointestinal Tumor Study Group. Ann Surg (1997) 1.32
Hematuria and rectal bleeding in the child with Klippel and Trenaunay syndrome. Ann Surg (1976) 1.31
A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection. Surg Gynecol Obstet (1986) 1.27
Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. J Clin Invest (1988) 1.22
Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials. Arch Intern Med (2000) 1.17
Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet (2000) 1.16
Mechanisms of impaired bone strength in type 1 and 2 diabetes. Nutr Metab Cardiovasc Dis (2010) 1.16
Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure. Vasc Health Risk Manag (2010) 1.15
Subtotal versus total gastrectomy for cancer of the lower two-thirds of the stomach: a new approach to an old problem. Br J Surg (1986) 1.15
Surgical treatment of hepatic metastases from colorectal cancer. Ann Surg (1986) 1.14
Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk. J Clin Endocrinol Metab (2001) 1.13
Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls. Dig Dis Sci (2005) 1.11
Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study. Calcif Tissue Int (1986) 1.10
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer. Br J Cancer (2006) 1.10
Cardiovascular effects of calcitonin gene-related peptides I and II in man. Circ Res (1987) 1.08
Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease. Biochem Biophys Res Commun (1999) 1.08
Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids. Br J Cancer (2006) 1.08
The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men. Calcif Tissue Int (2008) 1.08
Prognosis of patients after palliative surgical procedures for carcinoma of the stomach. Surg Gynecol Obstet (1987) 1.08
Effect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic postmenopausal women: a 1-year longitudinal study. Bone (2003) 1.07
Lack of mutation at codon 531 of SRC in advanced colorectal cancers from Italian patients. Br J Cancer (2001) 1.03
Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosis. Calcif Tissue Int (1988) 1.03
Cavitron Ultrasonic Surgical Aspirator (CUSA) in liver resection. Int Surg (1992) 1.03
A clinicopathologic study of primary hepatic carcinoid tumors. Cancer (1990) 1.02
Anaphylaxis in children: clinical and allergologic features. Pediatrics (1998) 1.01
Glucocorticoid-induced osteoporosis. Clin Rheum Dis (1986) 1.01
Comparison of nutritional status after total or subtotal gastrectomy. Nutrition (1992) 1.00
Dietary L-lysine and calcium metabolism in humans. Nutrition (1993) 1.00
Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. BMJ (1992) 1.00
Hyperuricemia and gout in thyroid endocrine disorders. Clin Exp Rheumatol (2002) 1.00
Sensitivity of Hemoccult test for large bowel cancer in high-risk subjects. Dig Dis Sci (1988) 1.00
Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans. Calcif Tissue Int (1984) 1.00
Quantitation of estrogen and androgen receptors in hepatocellular carcinoma and adjacent normal human liver. Dig Dis Sci (1991) 1.00
Chordoma: natural history and treatment results in 33 cases. J Surg Oncol (1988) 0.99
Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane. Bone (2006) 0.99
Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women. Bone (2001) 0.99
A posterior approach for the excision of sacral chordoma. J Bone Joint Surg Br (1987) 0.99
Validation of a food frequency questionnaire for nutritional calcium intake assessment in Italian women. Eur J Clin Nutr (2002) 0.98
Paget's disease of bone: diagnosis and management. BMJ (1996) 0.98
Results of extended surgery for cancer of the rectum and sigmoid. Br J Surg (1982) 0.98
Recommendations for the registration of new chemical entities used in the prevention and treatment of osteoporosis. Calcif Tissue Int (1995) 0.97
Most Helicobacter pylori-infected patients have specific antibodies, and some also have H. pylori antigens and genomic material in bile: is it a risk factor for gallstone formation? Dig Dis Sci (1998) 0.97
[Guidelines on prevention and treatment of vitamin D deficiency. Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS)]. Reumatismo (2011) 0.97
Bone ultrasonography at phalanxes in patients with Rett syndrome: a 3-year longitudinal study. Bone (2007) 0.96
Osteoporosis risk in patients with chronic obstructive pulmonary disease: the EOLO study. J Clin Densitom (2009) 0.96
Dual X-ray absorptiometry and bone ultrasonography in patients with Rett syndrome. Calcif Tissue Int (2001) 0.96
Cerebrotendinous xanthomatosis: pathophysiological study on bone metabolism. J Neurol Sci (1993) 0.96
Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate. Bone (2003) 0.96
Repeated hepatic resection for recurrent metastases from colorectal cancer. Br J Surg (1992) 0.96
Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical Densitometry. Semin Arthritis Rheum (1996) 0.95
Hepatic resections for colorectal metastases: the Italian multicenter experience. J Surg Oncol Suppl (1991) 0.95
Cardiovascular action of calcitonin gene-related peptide in humans. Calcif Tissue Int (1985) 0.95
Osteoporosis treatment and fracture incidence: the ICARO longitudinal study. Osteoporos Int (2008) 0.93
The occurrence of cholangitis after percutaneous biliary drainage: evaluation of some risk factors. Surgery (1988) 0.93
Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density. J Clin Endocrinol Metab (1998) 0.93
The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders. J Physiol Pharmacol (1999) 0.93
Morbidity and mortality after surgical resection of liver tumors. Analysis of 229 cases. Hepatogastroenterology (1992) 0.93
Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study. Osteoporos Int (2006) 0.93
Effects of prednisone and deflazacort on vertebral bone mass. Calcif Tissue Int (1985) 0.92
ST/G ACL reconstruction: double strand plus extra-articular sling vs double bundle, randomized study at 3-year follow-up. Scand J Med Sci Sports (2008) 0.92
Genetic markers of osteoarticular disorders: facts and hopes. Arthritis Res (2001) 0.91